Celiac disease has a name in every language on this map. What doesn't change is what it takes to live with it safely: reading labels, asking questions, trusting that “gluten-free” actually means gluten-free.
That's the work we show up for every day — not just the awareness part, but the verification part. On National Celiac Disease Awareness Day, observed in the US, we're thinking less about visibility and more about the systems that make gluten-free claims worth trusting.
Recalls:
UK alerts covered Minton & Donello Organic White Orzo and Capsicana Easy Going Mild Salsa for undeclared wheat or barley gluten, while France recalled Leclerc Pain protéines + after bread labeled GF was found to contain gluten.
(UK FSA; Coeliac UK; RappelConso)
A gluten-free hotel? Yes, they exist.
More hotels around the world are beginning to strengthen their GF procedures, staff training, and guest support systems — helping make travel feel more welcoming and accessible for people with gluten-related disorders, families, and groups.
Celiac disease raises the risk of eating disorders, a new drug shows effects beyond the gut, and a popular podcast reminded us why awareness still matters. Check out this edition of The Gluten-Free Brief: https://t.co/xoXrgpcmIw
The latest edition of The Gluten-Free Brief covers major new celiac research, undiagnosed case estimates, gluten-related recalls, a court ruling on gluten-free meals, and formulation changes affecting Peanut M&M’s. https://t.co/oUU62W2zyz
This edition of The GF Brief looks at why very small gluten doses still matter, what EEGs reveal about sleep in children with celiac disease, how skin conditions like dandruff may connect to celiac, and where policy is moving next on school meals. https://t.co/T90acZ3bv8
This edition of The Gluten‑Free Brief highlights global #glutenfree developments, from campus policy changes and national screening programs to new clinical data on pancreatitis risk, gluten‑removed beer, and kitchen cross‑contact.
#celiacdisease https://t.co/2FqhWNsiW2
In this edition of The Gluten-Free Brief, we bring evidence-based updates in policy, science, and access from the UK, Argentina, Spain, and the US. https://t.co/kIDoRSto6P
The Moghal & Soldera study (2025) found that stool testing has 85.1% sensitivity compared to 55.4% for urine for monitoring gluten intake. While urine captures intake within hours, stool testing identifies "hidden" exposures occurring over several days. (@Life_MDPI)
UK retailer M&S reports selling over 10k gluten-free "Colin the Caterpillar" cakes in the first 5 days of its launch. The success reflects high demand, with 79% of M&S shoppers buying gluten-free products manufactured via a dedicated production line. (@marksandspencer)